Thalys Medical Technology Group Corporation (SHA:603716)
China · Delayed Price · Currency is CNY 23.45
+0.11 (0.47%)
Apr 8, 2026, 2:05 PM CST
SHA:603716 Market Cap
SHA:603716 has a market cap or net worth of 5 billion as of April 7, 2026. Its market cap has increased by 143.37% in one year.
Market Cap
5.00B
Enterprise Value
5.40B
Revenue
1.25B
Ranking
n/a
PE Ratio
n/a
Stock Price
23.45
Market Cap Chart
Since October 31, 2016, SHA:603716's market cap has increased from 1.97B to 5.00B, an increase of 153.16%. That is a compound annual growth rate of 10.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 5.00B | 17.93% |
| Dec 31, 2025 | 4.24B | 213.84% |
| Dec 31, 2024 | 1.35B | -36.50% |
| Dec 29, 2023 | 2.13B | 0.51% |
| Dec 30, 2022 | 2.12B | -24.46% |
| Dec 31, 2021 | 2.80B | -14.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 8.58B |
| Cowealth Medical China | 8.02B |
| Shanghai Runda Medical Technology | 7.40B |
| Beijing Strong Biotechnologies,Inc. | 6.89B |
| Maccura Biotechnology Co.Ltd | 6.42B |
| SMO ClinPlus CO.,LTD. | 4.65B |
| Guangdong Hybribio Biotech | 4.19B |
| Shanghai Labway Clinical Laboratory | 3.90B |